Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 42,470 | 42,601 | 38,429 | 0 | 0 |
| Gross Profit | 42,470 | 42,601 | 38,429 | N/A | N/A |
| Operating Expenses | 72,792 | 57,297 | 44,184 | 43,407 | 74,434 |
| Operating Income | -30,322 | -14,696 | -5,755 | -22,107 | -74,434 |
| Other Income | 3,258 | 2,970 | 2,197 | 1,479 | 1,115 |
| Pre-tax Income | -27,064 | -11,726 | -3,558 | -20,628 | -73,319 |
| Net Income Continuous | -27,064 | -11,726 | -3,558 | -20,628 | -73,319 |
| Net Income | $-27,064 | $-11,726 | $-3,558 | $-20,628 | $-73,319 |
| EPS Basic Total Ops | -0.89 | -0.39 | -0.12 | -0.76 | -2.45 |
| EPS Basic Continuous Ops | -0.89 | -0.39 | -0.12 | -0.76 | -2.45 |
| EPS Diluted Total Ops | -0.89 | -0.39 | -0.12 | -0.76 | -2.45 |
| EPS Diluted Continuous Ops | -0.89 | -0.39 | -0.12 | -0.76 | -2.45 |
| EPS Diluted Before Non-Recurring Items | -0.89 | -0.39 | -0.12 | -0.69 | -1.12 |
| EBITDA(a) | $-30,873 | $-15,104 | $-5,920 | $-43,424 | $-74,382 |